Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Becker

Showing results (221-230 of 274) with videos related to

Pageof 28
Sort By:
NPJ Vaccines|August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activityHelena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Archives of Virology|November 4, 2010
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviationsJens H Kuhn, Stephan Becker, Hideki Ebihara, et al.
The Lancet. Infectious Diseases|October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trialMatthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Journal of Medicinal Chemistry|September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main ProteaseMark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
NPJ Vaccines|January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansLeonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Nature Medicine|October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVStefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Viruses|March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsFrancisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
The Journal of Infectious Diseases|October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, GermanyStephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Iscience|February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adultsMeryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Pageof 28

Showing results (221-230 of 274) with videos related to

Sort By:
Pageof 28
NPJ Vaccines|August 18, 2020
Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activityHelena Müller, Sarah Katharina Fehling, Jens Dorna, et al.
Archives of Virology|November 4, 2010
Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviationsJens H Kuhn, Stephan Becker, Hideki Ebihara, et al.
The Lancet. Infectious Diseases|October 10, 2024
Safety, immunogenicity, and optimal dosing of a modified vaccinia Ankara-based vaccine against MERS-CoV in healthy adults: a phase 1b, double-blind, randomised placebo-controlled clinical trialMatthijs P Raadsen, Christine Dahlke, Anahita Fathi, et al.
Journal of Medicinal Chemistry|September 30, 2022
Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main ProteaseMark S Cooper, Linlin Zhang, Mohamed Ibrahim, et al.
NPJ Vaccines|January 26, 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humansLeonie Mayer, Leonie M Weskamm, Anahita Fathi, et al.
Nature Medicine|October 9, 2019
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOVStefanie A Ehrhardt, Matthias Zehner, Verena Krähling, et al.
Viruses|March 22, 2019
Characterization of the Filovirus-Resistant Cell Line SH-SY5Y Reveals Redundant Role of Cell Surface Entry FactorsFrancisco J Zapatero-Belinchón, Erik Dietzel, Olga Dolnik, et al.
The Journal of Infectious Diseases|October 12, 2011
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, GermanyStephan Günther, Heinz Feldmann, Thomas W Geisbert, et al.
Iscience|February 28, 2022
No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adultsMeryem Seda Ercanoglu, Lutz Gieselmann, Sabrina Dähling, et al.
The EMBO Journal|July 14, 2021
Non-canonical proline-tyrosine interactions with multiple host proteins regulate Ebola virus infectionJyoti Batra, Hiroyuki Mori, Gabriel I Small, et al.
Pageof 28